Translation initiation complex eIF4F is a therapeutic target for dual mTOR kinase inhibitors in non-Hodgkin lymphoma-Reference-Cited by-同舟云学术

Translation initiation complex eIF4F is a therapeutic target for dual mTOR kinase inhibitors in non-Hodgkin lymphoma

Published:2015-03-20 Issue:11 Volume:6 Page:9488-9501
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Demosthenous Christos¹,Han Jing Jing¹,Stenson Mary J.¹,Maurer Matthew J.¹,Wellik Linda E.¹,Link Brian²,Hege Kristen³,Dogan Ahmet⁴,Sotomayor Eduardo⁵,Witzig Thomas¹,Gupta Mamta¹

Affiliation:

1. Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA

2. Department of Internal Medicine, University of Iowa College of Medicine, IA, USA

3. Celgene Corporation, San Francisco, CA, USA

4. Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA

5. Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MYC the oncogene from hell: Novel opportunities for cancer therapy;European Journal of Medicinal Chemistry;2024-03

2. Dependence of peripheral T‐cell lymphoma on constitutively activated JAK3: Implication for JAK3 inhibition as a therapeutic approach;Hematological Oncology;2023-10-24

3. The role of eIF4F-driven mRNA translation in regulating the tumour microenvironment;Nature Reviews Cancer;2023-05-04

4. Tissue-Specific microRNA Expression Profiling to Derive Novel Biomarkers for the Diagnosis and Subtyping of Small B-Cell Lymphomas;Cancers;2023-01-10

5. Translational Regulation by eIFs and RNA Modifications in Cancer;Genes;2022-11-06